The global microfluidic devices market revenue was around US$ 26.5 billion in 2022 and is estimated to reach US$ 163.4 billion by 2031, growing at a compound annual growth rate (CAGR) of 22.4% during the forecast period from 2023 to 2031.
Microfluidic devices exploit the chemical and physical properties of gases and liquids at a microscale. Microfluidic devices provide various benefits over conventionally sized systems. Microfluidics allows the analysis and usage of low volume of samples, reagents, and chemicals lowering the worldwide costs of applications.
Market Driving Factors
The surging interest of developers & manufacturers in the development of microfluidic devices boosts the market growth. This is mainly owing to the combined manufacturer's efforts to develop footprints in emerging markets. For instance, in January 2023, uFluidix, a leader in the custom fabrication of microfluidic devices made of Polydimethylsiloxane (PDMS) and thermoplastics established a call for manufacturing projects needing funding. Furthermore, the uFluidix team has successfully increased its manufacturing capacity over the last 12 months and is currently optimizing for new process variables in thermoplastic microfluidic chip manufacturing.
Applications of microfluidics for enhanced procedural outcomes are estimated to drive the market. Biomedical, bioscience and biotechnological research have benefited greatly from the utilization of microfluidic technology in a broad range of applications. It has recently raised the effectiveness of molecular research and enabled notable advances in several bioresearch domains.
The high expense of research and development for products based on technology and the scarcity of funding have been the main obstacles for the market.
Regional Analysis
North America dominated the market in terms of revenue and is estimated to maintain its dominance. This can be attributed to the immediate adoption of cutting-edge technologies by prominent regional players. Furthermore, surged R&D activities and the existence of major players also boost the market expansion.
Asia Pacific is estimated to dominate the market in terms of the largest share. This is primarily due to the increasing demand for early and immediate diagnosis of diseases. Furthermore, surging disposable income and investment in the adoption of microfluidic technology are also driving the market growth.
Segmentation Insights
Product Insight
The microfluidic components segment dominated the market in terms of growth rate and is estimated to maintain its dominance. This can be majorly attributed to the advancements in microfluidic devices and the surging prevalence of chronic diseases.
Application Insight
The in-vitro diagnostics segment dominates the market in terms of revenue. This is primarily owing to the surging prevalence of infectious diseases and the increase in cancer incidence.
The pharmaceutical & life science research and manufacturing segment is estimated to dominate the market in terms of the largest shares. This is owing to the surge in the use of microfluidics in pharmaceutical and drug delivery.
End User Insight
The hospitals & diagnostic centers segment dominated the market and is predicted to continue its dominance. This can be mainly attributed to the surge in the number of hospitals and increased demand for cutting-edge treatment.
Prominent Companies
Segmentation Outline
The global microfluidic devices market segmentation focuses on the Product, Application, End User, and Region.
By Product
By Application
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL MICROFLUIDIC DEVICES MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: MICROFLUIDIC DEVICES MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL MICROFLUIDIC DEVICES MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL MICROFLUIDIC DEVICES MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 MICROFLUIDIC-BASED DEVICES
5.3 MICROFLUIDIC COMPONENTS
5.3.1 MICROFLUIDIC CHIPS
5.3.2 FLOW & PRESSURE SENSORS
5.3.3 FLOW & PRESSURE CONTROLLERS
5.3.4 MICROFLUIDIC VALVES
5.3.5 MICROPUMPS
5.3.6 MICRONEEDLES
5.3.7 OTHER COMPONENTS
6 GLOBAL MICROFLUIDIC DEVICES MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 IN-VITRO DIAGNOSTICS
6.2.1 CLINICAL DIAGNOSTICS
6.2.2 POINT-OF-CARE TESTING
6.2.3 VETERINARY DIAGNOSTICS
6.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING
6.3.1 LAB ANALYTICS
6.3.2 MICRODISPENSING
6.3.3 MICROREACTION
6.4 THERAPEUTICS
6.4.1 DRUG DELIVERY
6.4.2 WEARABLE DEVICES
7 GLOBAL MICROFLUIDIC DEVICES MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS & DIAGNOSTIC CENTERS
7.3 ACADEMIC & RESEARCH INSTITUTES
7.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8 GLOBAL MICROFLUIDIC DEVICES MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL MICROFLUIDIC DEVICES MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 NORTIS INC.
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 PERKINELMER INC.
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 NANOSTRING
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 FLUIDIGM CORPORATION
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 IDEX CORPORATION
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 AGILENT TECHNOLOGIES INC.
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 BIORAD LABORATORIES INC.
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 BIOMÉRIEUX SA
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 ABBOTT LABORATORIES
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 DANAHER CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 LONZA GROUP
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 QIAGEN N.V.
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 ILLUMINA INC.
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 THERMO FISHER SCIENTIFIC INC.
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 FORTIVE CORPORATION
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.16 DOLOMITE MICROFLUIDICS
10.16.1 OVERVIEW
10.16.2 FINANCIAL PERFORMANCE
10.16.3 PRODUCT OUTLOOK
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.17 SMC CORPORATION
10.17.1 OVERVIEW
10.17.2 FINANCIAL PERFORMANCE
10.17.3 PRODUCT OUTLOOK
10.17.4 KEY DEVELOPMENTS
10.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved